CT
AGN

Caldwell Trust’s Allergan plc AGN Stock Holding History

Caldwell Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-770
Closed -$136K – 804
2020
Q1 		$136K Sell
770
-22
-3% -$4.14K 0.03% 278
2019
Q4 		$151K Buy
+792
New +$143K 0.02% 311

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Caldwell Trust's AGN Position: Q2 2020 in Review

Caldwell Trust sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 770 shares — an estimated $136K sold.

Caldwell Trust first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $151K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Caldwell Trust reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Caldwell Trust sold 770 Allergan plc shares in Q2 2020, an estimated $136K.
  • Caldwell Trust first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Caldwell Trust's Allergan plc position peaked at $151K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Caldwell Trust's 13F filing for Q2 2020, filed 2 Oct 2025.